Cargando…
Pseudolaric Acid B Inhibits Proliferation, Invasion, and Angiogenesis in Esophageal Squamous Cell Carcinoma Through Regulating CD147
BACKGROUND: Esophageal squamous cell carcinoma (ESCC) is a common malignant tumor of the digestive system. Studies have shown that pseudolaric acid B (PAB) has several pharmacological effects like anti-microtubule, anti-angiogenesis, and antitumor functions, while the effect and mechanism of PAB on...
Autores principales: | Yin, Zhe, Cai, Huarong, Wang, Zhiqiang, Jiang, Yuequan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7605399/ https://www.ncbi.nlm.nih.gov/pubmed/33149553 http://dx.doi.org/10.2147/DDDT.S269915 |
Ejemplares similares
-
Pseudolaric acid B inhibits proliferation in SW579 human thyroid squamous cell carcinoma
por: YU, JINGHUA, et al.
Publicado: (2015) -
Pseudolaric Acid B Inhibits Proliferation, Invasion and Epithelial-to-Mesenchymal Transition in Human Pancreatic Cancer Cell
por: Li, Xiaoyu, et al.
Publicado: (2018) -
Protocadherin 8 (PCDH8) Inhibits Proliferation, Migration, Invasion, and Angiogenesis in Esophageal Squamous Cell Carcinoma
por: Yu, Hong, et al.
Publicado: (2020) -
Pseudolaric acid B ameliorates synovial inflammation and vessel formation by stabilizing PPARγ to inhibit NF‐κB signalling pathway
por: Lu, Jiansen, et al.
Publicado: (2021) -
Pseudolaric acid B induces apoptosis in human rhabdomyosarcoma RD cells
por: Liu, Chunyu, et al.
Publicado: (2020)